Detailed information for compound 1312730

Basic information

Technical information
  • TDR Targets ID: 1312730
  • Name: 5,7-dihydroxy-4-(4-methoxyphenyl)chroman-2-on e
  • MW: 286.279 | Formula: C16H14O5
  • H donors: 2 H acceptors: 3 LogP: 2.36 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)C1CC(=O)Oc2c1c(O)cc(c2)O
  • InChi: 1S/C16H14O5/c1-20-11-4-2-9(3-5-11)12-8-15(19)21-14-7-10(17)6-13(18)16(12)14/h2-7,12,17-18H,8H2,1H3
  • InChiKey: OKBWVJGQTFYYQA-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5,7-dihydroxy-4-(4-methoxyphenyl)-2-chromanone
  • MEGxp0_001736
  • MLS000863585
  • SMR000440734
  • ACon1_000182

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens parathyroid hormone 1 receptor Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens polymerase (DNA directed), beta Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium tuberculosis Conserved hypothetical protein Get druggable targets OG5_130965 All targets in OG5_130965
Trypanosoma congolense mitochondrial DNA polymerase beta, putative Get druggable targets OG5_130965 All targets in OG5_130965
Leishmania mexicana mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Leishmania donovani mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Leishmania major mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Trypanosoma brucei mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Leishmania braziliensis mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Mycobacterium ulcerans hypothetical protein Get druggable targets OG5_130965 All targets in OG5_130965
Schistosoma japonicum ko:K04588 secretin receptor, putative Get druggable targets OG5_139196 All targets in OG5_139196
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative Get druggable targets OG5_130965 All targets in OG5_130965
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative Get druggable targets OG5_130965 All targets in OG5_130965
Trypanosoma brucei gambiense mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965
Leishmania infantum mitochondrial DNA polymerase beta Get druggable targets OG5_130965 All targets in OG5_130965

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative polymerase (DNA directed), beta 335 aa 303 aa 32.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi p450 reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0636 1 1
Trypanosoma brucei NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Leishmania major hypothetical protein, conserved 0.0243 0.3284 0.3033
Toxoplasma gondii flavodoxin domain-containing protein 0.0316 0.452 1
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Mycobacterium tuberculosis Conserved hypothetical protein 0.0192 0.2407 1
Trypanosoma brucei oxidoreductase-protein, putative 0.0072 0.036 0.036
Trypanosoma brucei NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Brugia malayi isocitrate dehydrogenase 0.0174 0.2103 0.1981
Trypanosoma brucei S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0243 0.3284 0.3284
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Schistosoma mansoni NADPH flavin oxidoreductase 0.0321 0.4603 0.4402
Trypanosoma brucei nitrate reductase, putative 0.0072 0.036 0.036
Brugia malayi FAD binding domain containing protein 0.0636 1 1
Plasmodium falciparum nitric oxide synthase, putative 0.0636 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0243 0.3284 0.5
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0636 1 1
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0636 1 1
Trypanosoma cruzi cytochrome-b5 reductase, putative 0.0072 0.036 0.036
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0636 1 1
Brugia malayi Cytochrome b5-like Heme/Steroid binding domain containing protein 0.0072 0.036 0.0211
Trypanosoma cruzi cytochrome-b5 reductase, putative 0.0072 0.036 0.036
Plasmodium falciparum isocitrate dehydrogenase [NADP], mitochondrial 0.0174 0.2103 0.1808
Trypanosoma cruzi reductase, putative 0.0072 0.036 0.036
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0636 1 1
Plasmodium vivax flavodoxin domain containing protein 0.0564 0.8764 0.8717
Trypanosoma cruzi oxidoreductase-protein, putative 0.0072 0.036 0.036
Trypanosoma brucei NADH-dependent fumarate reductase 0.0072 0.036 0.036
Schistosoma mansoni diflavin oxidoreductase 0.0316 0.452 0.4316
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Schistosoma mansoni cytochrome P450 reductase 0.0636 1 1
Trichomonas vaginalis sulfite reductase, putative 0.0636 1 1
Brugia malayi flavodoxin family protein 0.0243 0.3284 0.318
Onchocerca volvulus 0.0072 0.036 0.5
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0564 0.8764 0.8159
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0062 0.0192 0.0192
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0636 1 1
Toxoplasma gondii isocitrate dehydrogenase 0.0174 0.2103 0.4496
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0174 0.2103 0.1808
Echinococcus multilocularis methionine synthase reductase 0.0393 0.584 0.5684
Leishmania major cytochrome P450 reductase, putative 0.0564 0.8764 0.8717
Loa Loa (eye worm) FAD binding domain-containing protein 0.0393 0.584 0.5775
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0365 0.5356 0.5356
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0636 1 1
Brugia malayi diaphorase 0.0072 0.036 0.0211
Trypanosoma cruzi NADPH--cytochrome P450 reductase, putative 0.0243 0.3284 0.3284
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0636 1 1
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Echinococcus granulosus NADP dependent isocitrate dehydrogenase 0.0174 0.2103 0.1808
Plasmodium falciparum NADPH--cytochrome P450 reductase, putative 0.0243 0.3284 0.3033
Leishmania major mitochondrial DNA polymerase beta-PAK, putative 0.0173 0.2073 0.1777
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0243 0.3284 0.3284
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0636 1 1
Trypanosoma cruzi oxidoreductase-like protein, putative 0.0072 0.036 0.036
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0636 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0243 0.3284 0.5
Trypanosoma brucei isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0174 0.2103 0.2103
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0174 0.2103 0.1808
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0243 0.3284 0.3284
Leishmania major p450 reductase, putative 0.0636 1 1
Treponema pallidum flavodoxin 0.0243 0.3284 1
Toxoplasma gondii isocitrate dehydrogenase 0.0174 0.2103 0.4496
Entamoeba histolytica type A flavoprotein, putative 0.0243 0.3284 0.5
Leishmania major isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0174 0.2103 0.1808
Trypanosoma brucei NADH-cytochrome b5 reductase-like protein 0.0072 0.036 0.036
Trypanosoma cruzi p450 reductase, putative 0.0636 1 1
Echinococcus multilocularis NADP dependent isocitrate dehydrogenase 0.0174 0.2103 0.1808
Leishmania major mitochondrial DNA polymerase beta 0.0365 0.5356 0.5183
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Chlamydia trachomatis sulfite reductase 0.0393 0.584 1
Trypanosoma cruzi nitrate reductase, putative 0.0072 0.036 0.036
Toxoplasma gondii ferredoxin NADP+ oxidoreductase FNR 0.0072 0.036 0.0526
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0173 0.2073 0.2073
Giardia lamblia Hypothetical protein 0.0564 0.8764 1
Echinococcus granulosus methionine synthase reductase 0.0393 0.584 0.5684
Trypanosoma cruzi isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 0.0174 0.2103 0.2103
Mycobacterium tuberculosis Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) 0.0174 0.2103 0.8518
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei mitochondrial DNA polymerase beta 0.0365 0.5356 0.5356
Loa Loa (eye worm) isocitrate dehydrogenase 0.0174 0.2103 0.1981
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0636 1 1
Echinococcus multilocularis isocitrate dehydrogenase 0.0174 0.2103 0.1808
Trypanosoma cruzi isocitrate dehydrogenase, putative 0.0174 0.2103 0.2103
Loa Loa (eye worm) hypothetical protein 0.0636 1 1
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0636 1 1
Echinococcus multilocularis isocitrate dehydrogenase 2 (NADP+) 0.0174 0.2103 0.1808
Mycobacterium ulcerans hypothetical protein 0.0192 0.2407 0.2123
Loa Loa (eye worm) FAD binding domain-containing protein 0.0636 1 1
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0393 0.584 0.5684
Brugia malayi Isocitrate dehydrogenase 0.0174 0.2103 0.1981
Plasmodium vivax isocitrate dehydrogenase [NADP], mitochondrial, putative 0.0174 0.2103 0.1808
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0365 0.5356 0.5356
Loa Loa (eye worm) flavodoxin family protein 0.0243 0.3284 0.318
Trypanosoma brucei NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Schistosoma mansoni NADP-specific isocitrate dehydrogenase 0.0174 0.2103 0.1808
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Toxoplasma gondii NADH-cytochrome b5 reductase 1, putative 0.0072 0.036 0.0526
Entamoeba histolytica type A flavoprotein, putative 0.0243 0.3284 0.5
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Plasmodium vivax hypothetical protein, conserved 0.0243 0.3284 0.3033
Plasmodium falciparum S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0243 0.3284 0.3033
Loa Loa (eye worm) diaphorase 0.0072 0.036 0.0211
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0636 1 1
Giardia lamblia Nitric oxide synthase, inducible 0.0564 0.8764 1
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei mitochondrial DNA polymerase beta-PAK 0.0173 0.2073 0.2073
Trypanosoma brucei isocitrate dehydrogenase, putative 0.0174 0.2103 0.2103
Brugia malayi FAD binding domain containing protein 0.0393 0.584 0.5775
Trypanosoma cruzi NADH-cytochrome b5 reductase, putative 0.0072 0.036 0.036
Trypanosoma cruzi NADH-dependent fumarate reductase, putative 0.0072 0.036 0.036
Trypanosoma brucei NADH-dependent fumarate reductase 0.0072 0.036 0.036
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0636 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0243 0.3284 0.5
Loa Loa (eye worm) cytochrome b5 reductase 4 0.0072 0.036 0.0211
Toxoplasma gondii flavodoxin domain-containing protein 0.0316 0.452 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 2.6679 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 10.4179 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 11.2202 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 14.1254 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] ChEMBL. No reference
Potency (functional) 35.4813 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))] ChEMBL. No reference
Potency (functional) 70.7946 uM PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.